title: [Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)].
abstract: Efficacy of a low molecular weight heparin (Kabi 2165) was compared with that of non-fractionated heparin in the prevention of abdominal surgery postoperative venous thrombosis by means of a double-blind randomized trial in 79 patients. Determination of D. dimers in these patients allowed assessment of specificity of this assay for detection of postoperative venous thrombosis.
authors.affiliation: Département d'Anesthésiologie, C.H.U. Côte de Nacre, Caen.
authors.forename: A
authors.initials: A
authors.lastname: Le Querrec
authors.forename: A
authors.initials: A
authors.lastname: Derlon
authors.forename: J P
authors.initials: JP
authors.lastname: Deshayes
authors.forename: C
authors.initials: C
authors.lastname: Lefrançois
authors.forename: B
authors.initials: B
authors.lastname: Sillard
authors.forename: P
authors.initials: P
authors.lastname: Delassus
authors.forename: J F
authors.initials: JF
authors.lastname: Viel
authors.forename: A
authors.initials: A
authors.lastname: Kher
authors.forename: M
authors.initials: M
authors.lastname: Thomas
mesh_terms: D000005:Abdomen / Q000601:surgery; D001780:Blood Coagulation Tests; D004311:Double-Blind Method; D004341:Drug Evaluation; D005170:Factor X / Q000032:analysis; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D011897:Random Allocation; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D006495:Heparin, Low-Molecular-Weight; D005170:Factor X; D006493:Heparin
vernacular_title: Critères biologiques d'évaluation d'un traitement prophylactique par une héparine de bas poiids moléculaire (Kabi 2,165).